Objective: to evaluate the effect of low-calcium peritoneal dialysate and phosphate binder on calcium and phosphate abnormality and coronary artery calcification of end-stage renal disease patients.
目的：评价低钙透析液和含钙的磷结合剂治疗对终末期肾病腹膜透析患者钙磷代谢紊乱和冠状动脉钙化进展的影响。
Conclusion Combined heart kidney transplantation from the same donor is an effective method for patients with end stage heart disease and renal failure.
结论心肾联合移植是挽救终末期心脏病合并肾功能衰竭病人生命的有效方法。
Objective To establish and optimize the two-dimensional gel electrophoresis technical platform for the blood serum proteome research in patients with end stage renal disease(ESRD).
目的建立和优化终末期肾病患者血清蛋白质组研究的双向电泳及相关技术，并与正常血清蛋白图谱比较。
Objective To detect the carotid elasticity quantitatively in end-stage renal disease(ESRD) patients using echo-tracking(ET)technique.
目的探讨回声跟踪（ET）技术对终末期肾病（ESRD）患者颈动脉弹性的检测及其意义。
Objective to investigate the acute effect of arterial function and explore the influence factor on hemodialysis patients with end-stage renal disease (ESRD).
目的探讨单次血液透析对终末期肾病(ESRD)患者动脉功能的急性效应及其影响因素。
Objective: to study the quality of life of end stage renal disease patients undergoing peritoneal dialysis (PD).
目的调查终末期肾功能衰竭腹膜透析患者的生命质量。
Objective To evaluate the QOL of family caregivers of patients with end-stage renal disease.
目的评估终末期肾病患者家庭照料者的生活质量。
Objective To evaluate the effect of 1, 25 - (OH) 2d3 on cardiovascular mortality among the patients with end-stage renal disease (ESRD) and on the treatment of supporting haemodialysis.
目的：评估1,25- (O H)2d 3对终末期肾脏疾病维持性血液透析病人心脏意外事件发生率的影响。
Objective:To compare disease activity in patients with systemic lupus erythematosus (SLE) before and after the onset of end-stage renal failure.
目的：比较系统性红斑狼疮（SLE）病人在终末期肾衰前后狼疮的活动性。
Objective To investigate the anxiety-depression level in the patients with firstly-diagnosed end-stage renal disease (ESRD) and its influencing factor.
目的探讨终末期肾病（ESRD）首诊患者的焦虑-抑郁水平及其影响因素。
We considered myocardial infarction and stroke as the primary outcomes. We excluded studies in patients with end-stage renal disease.
我们把心肌梗塞和中风当作主要评估结果，排除具有末期肾病病人的所有研究。
Peritoneal dialysis (PD) using glucose-based dialysate is one of the effective treatment for patients with end-stage renal disease.
使用葡萄糖透析液进行腹膜透析透是治疗终末期肾脏病的有效措施之一。
Background and ObjectiveDiabetic nephropathy (DN) is the leading cause of end-stage renal disease and a major contributing cause of morbidity and mortality in patients with diabetes.
研究背景和目的糖尿病肾病(DN)是导致终末期肾病的主导因素，也是糖尿病患者致死、致残的主要原因。
FGF23 levels were significantly higher in the patients who later died or reached end-stage renal disease than in those who didn't.
死亡者及发生终末期肾病者的FGF23水平，显示高于未发生这类情况者。
A considerable proportion of the patients will be progressed to the end stage renal disease.
其中有相当一部分患者将进展至终末期肾病。
Abstract: as an effective renal replacement therapy, peritoneal dialysis is widely used in patients with end-stage kidney disease.
摘要：腹膜透析作为一种有效的肾脏替代治疗，在终末期肾病中运用日渐广泛，甚至成为肾脏替代治疗的首选方案。
Abstract: as an effective renal replacement therapy, peritoneal dialysis is widely used in patients with end-stage kidney disease.
摘要：腹膜透析作为一种有效的肾脏替代治疗，在终末期肾病中运用日渐广泛，甚至成为肾脏替代治疗的首选方案。
应用推荐